Role of Metformin Monotherapy Vs Metformin Plus Dapagliflozin in New Onset T2DM Among 40 Plus Obese Women in Glycaemic Control

Role of Metformin Monotherapy Vs Metformin Plus Dapagliflozin in New Onset T2DM Among 40 Plus Obese Women in Glycaemic Control

Objective: A Randomized, open-label comparative clinical study was conducted to evaluate the comparative efficacy and safety of Metformin 500mg twice daily versus Metformin 500mg twice daily Plus Dapagliflozin (10mg) once daily in achieving glycemic control among new onset T2DM in forty plus obese...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Amarjeet Singh, Ashima Badyal, Suman Kotwal, Vishal R Tandon
Formaat: Artikel
Taal:English
Gepubliceerd in: Dr. Annil Mahajan 2024-10-01
Reeks:JK Science
Onderwerpen:
Metformin plus Dapagliflozin
SGLT2 inhibitors
Post menopausal
Obese
Women
Online toegang:http://journal.jkscience.org/index.php/JK-Science/article/view/308

Internet

http://journal.jkscience.org/index.php/JK-Science/article/view/308

Gelijkaardige items